LEUKEMIA & LYMPHOMA Journal

publication venue for

Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review 2022
The landscape of trials for smoldering multiple myeloma: endpoints, trial design, and lessons learnt 2021
Renal insufficiency in multiple myeloma: a systematic review and meta-analysis of all randomized trials from 2005-2019 2021
Impact of anti-CD38 therapy in multiple myeloma with high-risk cytogenetics: systematic review and meta-analysis 2020

International Standard Serial Number (ISSN)

1042-8194

Electronic International Standard Serial Number (EISSN)

1029-2403

journal abbreviation

LEUKEMIA LYMPHOMA